Related Experiment Videos
Cyclin D1 expression in acute leukemia
Salah Aref1, M Mabed, M El-Sherbiny
1Hematology Unit, Clinical Pathology Department, Mansoura Faculty of Medicine, Mansoura, Egypt. salaharef@yahoo.com
Hematology (Amsterdam, Netherlands)
|March 9, 2006
Summary
Cyclin D1 protein is overexpressed in acute lymphoblastic leukemia (ALL) but not in acute myeloid leukemia (AML), suggesting different roles in these blood cancers.
Area of Science:
- Oncology
- Cell Biology
- Hematology
Background:
- Cell cycle dysregulation is crucial in cancer development.
- Cyclin D1 overexpression is noted in solid tumors and some lymphoid malignancies.
- Its role in acute leukemia remains largely uncharacterized.
Purpose of the Study:
- To investigate the expression of cyclin D1 protein in acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL).
- To compare cyclin D1 levels in leukemia patients with healthy controls.
Main Methods:
- Analyzed cyclin D1 protein expression using flow cytometry.
- Studied 40 newly diagnosed AML patients, 10 ALL patients, and 11 healthy controls.
Main Results:
- Cyclin D1 expression was similar in AML patients and controls.
- Overexpression of cyclin D1 was observed in 40% of ALL patients compared to controls.
- In ALL, cyclin D1 overexpression correlated with blast cell counts and clinical features like lymphadenopathy and organomegaly.
Conclusions:
- Cyclin D1 overexpression may have distinct biological significance in AML versus ALL.
- Findings highlight potential differences in cell cycle regulation between these acute leukemia subtypes.